Objective: To evaluate the noninferiority of rituximab compared to ocrelizumab in preventing new or enlarging T2-weighted MRI lesions in patients with newly dia

Objective: To evaluate the effectiveness of a rapid 4-gene mRNA test, qMIDSV3, as a triage tool for distinguishing oral squamous cell carcinoma from low-risk or

Objective: To evaluate the association between urinary biomarkers of environmental chemical exposure during pregnancy and gestational length and birth weight-fo

Objective: To evaluate the impact of robotic-assisted total knee arthroplasty (TKA) on revision rates compared to conventional TKA. Approach: Study Design: A Le

Objective: To explore the increasing trend of physicians running for office in the 2026 election cycle and its implications. Approach: Overview of Trends: A rec

Objective: To assess the efficacy of topical NSAIDs as adjunctive therapy for diabetic macular edema (DME). Approach: Study Design: Systematic review and meta-a

Objective: To investigate intraocular pressure (IOP) changes during hemodialysis in patients with end-stage kidney disease (ESKD). Approach: Study Design: A pro

Objective: To outline Ocular Therapeutix's plans for submitting a New Drug Application for AXPAXLI in wet AMD. Approach: FDA Meeting: Ocular Therapeutix held a

Objective: To highlight the importance of communication, education, and support in genomic medicine, emphasizing the gap between achieving technical milestones

Objective: To update breast cancer reporting protocols in alignment with the latest WHO classifications and recommendations. Approach: Updates Overview: The Col

Objective: To clarify the structural origins of defect peaks in high-temperature carbon materials and enhance Raman sensitivity for gas detection. Approach: Car

Objective: To investigate how honeybee queens transfer pesticide residues into their eggs when colony-level defenses are overwhelmed. Approach: Study Design: Th

Objective: To report on recent advancements in cell and gene therapies, including the approval of Tregzi and other notable studies. Approach: FDA Approval of Tr

Objective: To explore how cell and gene therapy (CGT) companies, payers, and healthcare systems are rethinking pricing and reimbursement models for advanced the

Objective: To illustrate a structured clinical approach for diagnosing and managing immune checkpoint inhibitor (ICI)-associated aseptic meningitis in lung canc

Objective: To synthesize evidence around the challenges in the clinical management of Adult Degenerative Scoliosis (ADS), focusing on diagnostic difficulties, p

Objective: To develop 'armored' anti-CD19 CAR-NK cells coexpressing GITR ligand (GITRL) to target malignant B cells and to counteract Treg-mediated suppression.

Objective: To synthesize current research on the mechanisms of action, clinical applications, and safety profiles of Janus kinase (JAK) inhibitors in the manage